phospholipids
Small moleculeexperimental
Phospholipids are a class of lipids whose molecule has a hydrophilic "head" containing a phosphate group and two hydrophobic "tails" derived from fatty acids, joined by an alcohol residue. Marine phospholipids typically have omega-3 fatty acids EPA and DHA integrated as part of the phospholipid molecule. The phosphate group can be modified with simple organic molecules such as choline, ethanolamine or serine. — Wikipedia
Clinical trial activity
7 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
2
Phase 4
2
Earliest trial started Sep 1, 2004 (NCT00089986)
Timeline
Indications
Approved for
Mechanism of action
- Unspecified targetSupplementation
supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaPhospholipid ↗
Also known as
- gr270773
- phospholipids
- phospholipids
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06749028 | N/A | Dec 17, 2024 | Fundacion del Caribe para la Investigacion Biomedica, Naturmega |
| NCT04585334 | Phase 4 | Mar 25, 2019 | Fidia Advanced Biopolymers |
| NCT02542449 | Phase 4 | Apr 1, 2013 | Istituto Auxologico Italiano |
| NCT01935817 | Phase 3 | Jun 1, 2010 | University of Catania |
| NCT01957319 | Phase 3 | Feb 1, 2010 | University of Catania |
| NCT00158769 | Phase 1 | Mar 1, 2005 | GlaxoSmithKline |
| NCT00089986 | Phase 2 | Sep 1, 2004 | GlaxoSmithKline |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 2 | 2 | 2 | 2004 |
| University of Catania | Academic/Hospital | 2 | 2 | 1 | 2010 |
| Fidia Advanced Biopolymers | For profit | 1 | 1 | 1 | 2019 |
| Fundacion del Caribe para la Investigacion Biomedica | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Istituto Auxologico Italiano | Academic/Hospital | 1 | 1 | 1 | 2013 |
| Naturmega | For profit | 1 | 0 | 1 | 2024 |
6 organizations
Page 1 / 1